Pezzi Christopher M, Mallin Katherine, Mendez Andres Samayoa, Greer Gay Emmelle, Putnam Joe B
Department of Surgery, Abington Health, Abington, Pa.
American College of Surgeons, Commission on Cancer, Chicago, Ill.
J Thorac Cardiovasc Surg. 2014 Nov;148(5):2269-77. doi: 10.1016/j.jtcvs.2014.07.077. Epub 2014 Aug 4.
To evaluate 30-day and 90-day mortality after major pulmonary resection for lung cancer including the relationship to hospital volume.
Major lung resections from 2007 to 2011 were identified in the National Cancer Data Base. Mortality was compared according to annual volume and demographic and clinical covariates using univariate and multivariable analyses, and included information on comorbidity. Statistical significance (P<.05) and 95% confidence intervals were assessed.
There were 124,418 major pulmonary resections identified in 1233 facilities. The 30-day mortality rate was 2.8%. The 90-day mortality rate was 5.4%. Hospital volume was significantly associated with 30-day mortality, with a mortality rate of 3.7% for volumes less than 10, and 1.7% for volumes of 90 or more. Other variables significantly associated with 30-day mortality include older age, male sex, higher stage, pneumonectomy, a previous primary cancer, and multiple comorbidities. Similar results were found for 90-day mortality rates. In the multivariate analysis, hospital volume remained significant with adjusted odds ratios of 2.1 (95% confidence interval [CI], 1.7-2.6) for 30-day mortality and 1.3 (95% CI, 1.1-1.6) for conditional 90-day mortality for the hospitals with the lowest volume (<10) compared with those with the highest volume (>90). Hospitals with a volume less than 30 had an adjusted odds ratio for 30-day mortality of 1.3 (95% CI, 1.2-1.5) compared with those with a volume greater than 30.
Mortality at 30 and 90 days and hospital volume should be monitored by institutions performing major pulmonary resection and benchmarked against hospitals performing at least 30 resections per year.
评估肺癌肺叶切除术后30天和90天的死亡率,以及与医院手术量的关系。
在国家癌症数据库中确定2007年至2011年期间的肺叶切除术。使用单因素和多因素分析,根据年手术量、人口统计学和临床协变量比较死亡率,并纳入合并症信息。评估统计学显著性(P<0.05)和95%置信区间。
在1233家机构中确定了124418例肺叶切除术。30天死亡率为2.8%。90天死亡率为5.4%。医院手术量与30天死亡率显著相关,手术量少于10例的死亡率为3.7%,手术量90例或更多的死亡率为1.7%。与30天死亡率显著相关的其他变量包括年龄较大、男性、分期较高、全肺切除术、既往原发性癌症和多种合并症。90天死亡率也有类似结果。在多因素分析中,与手术量最高(>90例)的医院相比,手术量最低(<10例)的医院30天死亡率的调整优势比为2.1(95%置信区间[CI],1.7-2.6),90天条件死亡率的调整优势比为1.3(95%CI,1.1-1.6)。手术量少于30例的医院与手术量大于30例的医院相比,30天死亡率的调整优势比为1.3(95%CI,1.2-1.5)。
进行肺叶切除术的机构应监测30天和90天的死亡率以及医院手术量,并与每年至少进行30例切除术的医院进行对比。